Peptides and compounds that bind to a thrombopoietin receptor
US6465430B1 · kind B1 · utility
24Cited by
11References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 13, 2000 |
| Grant date | Oct 15, 2002 |
| Priority date | — |
| Expiry date | Apr 13, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Receptors are peptides and peptide mimetics that bind to and activate the thrombopoietin receptor. Such peptides and peptide mimetics are useful in methods for treating hematological disorders and particularly, thrombocytopenia resulting from chemotherapy, radiation therapy, or bone marrow transfusions as well as in diagnostic methods employing labeled peptides and peptide mimetics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.